CharlesConwayMD

Psychiatry • Saint Louis, MO

Associate Professor of Psychiatry, Washington University St Louis

Join to view full profile

Dr. Conway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Conway's full profile

Already have an account?

Office
1 Barnes Jewish Hospital Plz
Saint Louis, MO 63110
Phone+1 314-286-1700

Fax+1 314-970-9094

Education & Training

Duke University HospitalResidency, Psychiatry, 1995 - 1999
University of Missouri-Columbia School of MedicineClass of 1995

Certifications & Licensure

MO State Medical License 1999 - 2026
NC State Medical License 1997 - 2000
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Treatment-Resistant Depression Registry Start of enrollment: 2006 Jan 01
Completed
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression Start of enrollment: 2009 May 01
Completed
Not Applicable
fMRI Study of Treatment Changes in Major Depression Start of enrollment: 2009 Feb 01
Completed
Not Applicable
Genomics Used to Improve DEpression Decisions Start of enrollment: 2014 Apr 01
Completed
Not Applicable
Adaptive tDCS for Treatment-Resistant MDD Start of enrollment: 2017 Apr 14
Active, not recruiting
Not Applicable
NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits Start of enrollment: 2017 Jan 27
Terminated
Phase 1
Nitrous Oxide- Suicidal Ideation Start of enrollment: 2018 Oct 30
Enrolling by invitation
Phase 1
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression Start of enrollment: 2019 Sep 26
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report.
Victoria C de Leon, Rebecca M Allen, João Quevedo, Patricio Riva-Posse, Scott T Aaronson
Journal of Affective Disorders. 2024-12-23
1 citations
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-c...
A John Rush, Charles R Conway, Scott T Aaronson, Mark S George, Patricio Riva-Posse
Brain Stimulation. 2024-12-18
1 citations
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Mark S George, John Zajecka
Brain Stimulation. 2024-12-18

Journal Articles

Neurostimulation for Depression in Epilepsy☆
Charles R Conway, Steven C Schachter, Epilepsy & Behavior

Press Mentions

Vagus Nerve Stimulation Shows Positive Treatment Effect in DepressionJanuary 3rd, 2025
Vagus Nerve Stimulation May Relieve Treatment-Resistant Depression, Study FindsDecember 19th, 2024
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant DepressionDecember 18th, 2024
Join now to see all